INDEPTH - DSS UNIVERSITIES:
SHORT TERM FELLOWSHIPS
Kilifi DSS, Navrongo Ghana
|
1.
Name of site: |
Kilifi
Demographic Surveillance Site |
|
2.
City/Country: |
Kilifi,
Kenya |
|
3.
Site Leader: |
Thomas Williams |
|
4.
Site contact person for this programme: |
Thomas Williams
P. O. Box 230, Kilifi, Kenya
Phone +254 41 522063
Fax +254 41 522390
Email: TWilliams@kilifi.mimcom.net |
|
5.
Short description of site: |
The KEMRI Wellcome Trust
Research Programme, a collaboration between the Kenya Medical Research
Institute and the University of Oxford UK, was first established in
1989. The programme has two offices: one in Kilifi, and a second in
Nairobi, in the grounds of the Kenyatta National Hospital. The Kilifi
unit is a major centre for clinical, epidemiological and laboratory
science with a focus on malaria and other infectious diseases. The
Kilifi DSS, which was established in 2001 with funds awarded by the
Wellcome Trust UK, monitors a mainly rural population of 220,000 people
living in an area of 700km2 surrounding the District Hospital in Kilifi. |
|
6.
Research objectives: |
The Kilifi DSS supports
a wide range of epidemiological research at the KEMRI Wellcome Programme.
It provides: (a) accurate denominator data that is used in estimating
the incidence of a range of diseases and outcomes; (b) a sampling frame
for control selection in case-control studies; (c) a framework for
establishing intervention studies; (d) a system for monitoring
prospectively the impact of epidemics (such as HIV) and policy changes
(such as the roll out of free bed nets in the community). |
|
7.
Priority research areas: |
Host genetic
susceptibility to infectious
Epidemiology and immunology
Epidemiology of RSV
Epidemiology and Immunology
HIV trial site preparation
Malaria vaccine trials
Pneumococcal vaccine trials |
|
8.
Sample publications in the last five years: |
Bejon, P., Mwacharo, J.,
Kai, O.K., Todryk, S., Keating, S., Lang, T., Gilbert, S.C., Peshu, N.,
Marsh, K., Hill, A.V. (2006) “Immunogenicity of the candidate malaria
vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic
antigen ME-TRAP in 1-6 year old children in a malaria endemic area.”
Vaccine.
Brent A.J., Oundo J., Mwangi I., Ochola L., Lowe B., Berkley J.A. (2006)
“Salmonella bacteremia in Kenyan children.” Pediatric Infectious
Diseases Journal 25: 230-236.
Brent, A.J., Ahmed, I., Ndiritu, M. Lewa, P. Ngetsa, C. Lowe, B. Bauni,
E. English, M. Berkley, J.A. Scott, J.A. (2006). "Incidence of
clinically significant bacteraemia in children who present to hospital
in Kenya: community-based observational study." Lancet 367(9509): 482-8.
Wambua, S., Mwangi, T.W., Kortok, M., Uyoga, S.M., Macharia, A.W.,
Mwacharo, J.K., Weatherall, D.J., Snow, R.W., Marsh, K., Williams, T.N.
(2006) “The Effect of alpha(+)-Thalassaemia on the Incidence of Malaria
and Other Diseases in Children Living on the Coast of Kenya.” PLoS
Medicine 3: e158. |
|
9.
Description of areas, or example of research
questions site is interested in for which it will welcome collaboration
from the university: |
|
|
10.
Description of existing staff and competence in data analysis |
Research Scientists: 3
Clinical Officers: 10
Nurses: 21
Drug dispensing clerks: 3
IT Analyst: 1
Database and ICT: 6
Lab technicians: 5
EEG technician: 1
Assistant Research coordinators: 2
Educational Assessors: 3
Play Therapist: 2
Ward and OPD aids: 22
Field Workers: 25
Statisticians / Bio-Statisticians: 1
Field Supervisors: 4
Social Scientists: 1 |
|
11.
Period of time / length of time site can host a visiting researcher: |
|
|
12.
Will your site welcome a PhD student (supervised by staff in the
population programme) to work on available data to answer questions you
are interested in? |
|
|
13.
Any other issues you think are relevant to the programme / suggestions: |
|
For more information, please contact:
Back
Dr. Osman Sankoh
Deputy Executive Director
INDEPTH Network
Accra, Ghana
Email :
osman.sankoh@indepth-network.org
Tel.: +233 21 519394
|
|